Mubadala

Ansa Biotechnologies

Ansa is a synthetic biology company whose mission is to develop automated technology to synthesize strands of DNA in a fast, reliable and non-toxic matter.

Ansa is a synthetic biology company whose mission is to develop automated technology to synthesize strands of DNA in a fast, reliable and non-toxic matter.

Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years.

Ansa increased the single-write lengths it can achieve from 10mers in Jun-18 to 50mers by summer of 2019 and to 100mers by early 2020.

Other Pharmaceutical & Medical Technology Assets

  • Alloy Therapeutics

    Alloy is a biotechnology company that is developing and commercializing drug discovery platforms and services

    Read more
  • Ciitizen

    Ciitizen is a clinical trial patient recruitment platform that takes a patient-centric approach (versus provider/payer/pharma-centric) to establish a high-quality double-sided marketplace for matching patients and trials.

    Read more
  • Collective Health

    Collective Health (“CH”) is an enterprise software company building an end-to-end self-insurance platform to help employers process, manage and analyze health benefits.

    Read more
  • Outset Medical

    Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.

    Read more
  • Datavant

    Datavant's mission is to connect the world's health data to improve patient outcomes.

    Read more
  • Certara

    Certara accelerates medicines using its proprietary biosimulation software and technology to transform traditional drug discovery and development.

    Read more